Effect of aging and diabetes on the enteroinsular axis

Journals of Gerontology - Series A Biological Sciences and Medical Sciences

Volumn 56, Issue 9, 2001, Pages M575-M579

  Korosi, J ^a   McIntosh, C H S ^a   Pederson, R A ^a   Demuth, H U ^a   Habener, J F ^a   Gingerich, R ^a   Egan, J M ^a   Elahi, D ^a   Meneilly, G S ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

DIPEPTIDYL PEPTIDASE IV; GLUCAGON LIKE PEPTIDE 1; GLUCOSE; INSULIN; POLYPEPTIDE;

AGED; AGING; ARTICLE; BODY MASS; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; ENTEROINSULAR AXIS; FEMALE; HORMONE RESPONSE; HUMAN; INSULIN LIKE ACTIVITY; MALE; ORAL GLUCOSE TOLERANCE TEST; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

ADULT; AGED; AGED, 80 AND OVER; AGING; ANTIGENS, CD26; DIABETES MELLITUS; FEMALE; GASTRIC INHIBITORY POLYPEPTIDE; GLUCAGON; GLUCAGON-LIKE PEPTIDE 1; HUMANS; INSULIN; INTESTINES; ISLETS OF LANGERHANS; MALE; PEPTIDE FRAGMENTS; PROTEASE INHIBITORS; PROTEIN PRECURSORS;

EID: 0034868494     PISSN: 10795006     EISSN: None     Source Type: Journal    
DOI: 10.1093/gerona/56.9.M575     Document Type: Article

References (32)

1. The incretin concept and its relevance to diabetes
2. Catalytic mechanism of dipeptidyl peptidase IV
3. Dipeptidyl-peptidase IV hydrolyzes gastric inhibitory polypeptide, glucagon-like-peptide-1 (7-36), and peptide histidine methionine and is responsible for their degradation in human serum
4. Degradation of glucose-dependent insulinotropic polypeptide and truncated glucagon-like-peptide 1 in vitro and in vivo by dipeptidyl peptidase IV
5. Investigation of glucose-dependent insulinotropic polypeptide (1-42) and glucagon-like peptide-1 (70-36) degradation in vitro by dipeptidyl peptidase IV using matrix-assisted laser desorption/ioniza-tion time of flight mass spectrometry
6. Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in US adults
7. The effect of age and glycemic level on the response of the β-cell to glucose-dependent insulinotropic polypeptide and peripheral tissue sensitivity to endogenously released insulin
8. Increased disorderliness of basal insulin release, attenuated insulin secretory burst mass, and reduced ultradian rhythmicity of insulin secretion in older individuals
9. NIDDM in the elderly
10. Metabolic alterations in middle-aged and elderly obese patients with type 2 diabetes
11. The effect of age sex on the response of enteropancreatic polypeptides to oral glucose
12. The enteric enhancement of glucose-stimulated insulin release: The role of GIP in aging, obesity, and non-insulin-dependent diabetes mellitus
13. Effects of age on concentrations of plasma cholecystokinin, glucagon-like peptide 1, and peptide YY and their relation to appetite and pyloric motility
14. The aging entero-insular axis
15. The insulinotropic actions of glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (7-37) in normal and diabetic subjects
16. Inhibition of the activity of dipeptidyl-peptidase IV as a treatment for type 2 diabetes
17. Improved glucose tolerance in Zucker fatty rats by oral administration of the Dipeptidyl Peptidase IV inhibitor isoleucine thiazolidide
18. The enteroinsular axis in dipeptidyl peptidase IV-negative rats
19. Glucagon physiology and aging: Evidence for enhanced hepatic sensitivity
20. Insulin and glucagon relationships during aging in man
21. Effects of age on fasting levels of pancreatic hormones in man
22. Attenuated glucose recovery from hypoglycemia in the elderly
23. Altered responses to hypoglycemia of healthy elderly people
24. Counterregulatory hormone responses to hypoglycemia in the elderly patient with diabetes
25. The effect of glyburide on beta-cell sensitivity to glucose-dependent insulinotropic polypeptide
26. Different aetiologies of type 2 diabetes mellitus in obese and non-obese subjects
27. Immunoreactive gastric inhibitory polypeptide
28. A novel form of dipeptidylpeptidase IV found in human serum: Isolation, characterization, and comparison with T lymphocyte membrane dipeptidylpeptidase IV (CD26)
29. Dipeptidyl peptidase IV from human serum: Purification, characterization, and N-terminal amino acid sequence
30. Human serum dipeptidyl peptidase IV (DPPIV) and its unique properties
31. Serum high molecular weight dipeptidyl peptidase IV (CD26) is similar to a novel antigen DPPT-L released from activated T cells
32. Dipeptidyl-peptidase IV-β: Further characterization and comparison to dipeptidyl-peptidase IV activity of CD26